Mechanisms of immune evasion of human neuroblastoma - PubMed (original) (raw)
Review
Mechanisms of immune evasion of human neuroblastoma
Lizzia Raffaghello et al. Cancer Lett. 2005.
Abstract
Neuroblastoma (NB) is a common neuroectodermal tumor of childhood with low response to conventional therapy in patients with advanced stage disease. Among novel strategies, immumotherapy has attracted much interest. However, scanty information is available about the immunogenicity of human NB. Here, we review our data showing that human NB may evade the control mediated by T cytotoxic lymphocytes and natural killer (NK) cells through multiple mechanisms: (i) downregulation of HLA class I molecules and antigen processing machinery components (ii) downregulation of activating ligands for the activating immunoreceptor NKG2D expressed by cytotoxic T lymphocytes and NK cells. Additional mechanisms of immune evasion used by human NB cells are discussed.
Similar articles
- Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma.
Raffaghello L, Prigione I, Airoldi I, Camoriano M, Levreri I, Gambini C, Pende D, Steinle A, Ferrone S, Pistoia V. Raffaghello L, et al. Neoplasia. 2004 Sep-Oct;6(5):558-68. doi: 10.1593/neo.04316. Neoplasia. 2004. PMID: 15548365 Free PMC article. - Differentiation induced by physiological and pharmacological stimuli leads to increased antigenicity of human neuroblastoma cells.
Carlson LM, Påhlman S, De Geer A, Kogner P, Levitskaya J. Carlson LM, et al. Cell Res. 2008 Mar;18(3):398-411. doi: 10.1038/cr.2008.27. Cell Res. 2008. PMID: 18268541 - IRF1 and NF-kB restore MHC class I-restricted tumor antigen processing and presentation to cytotoxic T cells in aggressive neuroblastoma.
Lorenzi S, Forloni M, Cifaldi L, Antonucci C, Citti A, Boldrini R, Pezzullo M, Castellano A, Russo V, van der Bruggen P, Giacomini P, Locatelli F, Fruci D. Lorenzi S, et al. PLoS One. 2012;7(10):e46928. doi: 10.1371/journal.pone.0046928. Epub 2012 Oct 5. PLoS One. 2012. PMID: 23071666 Free PMC article. - Immunogenicity of human neuroblastoma.
Prigione I, Corrias MV, Airoldi I, Raffaghello L, Morandi F, Bocca P, Cocco C, Ferrone S, Pistoia V. Prigione I, et al. Ann N Y Acad Sci. 2004 Dec;1028:69-80. doi: 10.1196/annals.1322.008. Ann N Y Acad Sci. 2004. PMID: 15650233 Review. - Modulation of HLA expression in human cytomegalovirus immune evasion.
Lin A, Xu H, Yan W. Lin A, et al. Cell Mol Immunol. 2007 Apr;4(2):91-8. Cell Mol Immunol. 2007. PMID: 17484802 Review.
Cited by
- Current Knowledge and Perspectives of Immunotherapies for Neuroblastoma.
Mao C, Poimenidou M, Craig BT. Mao C, et al. Cancers (Basel). 2024 Aug 17;16(16):2865. doi: 10.3390/cancers16162865. Cancers (Basel). 2024. PMID: 39199637 Free PMC article. Review. - Adoptive cell therapy in paediatric extracranial solid tumours: current approaches and future challenges.
Zappa E, Vitali A, Anders K, Molenaar JJ, Wienke J, Künkele A. Zappa E, et al. Eur J Cancer. 2023 Nov;194:113347. doi: 10.1016/j.ejca.2023.113347. Epub 2023 Sep 18. Eur J Cancer. 2023. PMID: 37832507 Free PMC article. Review. - Biological Insight and Recent Advancement in the Treatment of Neuroblastoma.
Rivera Z, Escutia C, Madonna MB, Gupta KH. Rivera Z, et al. Int J Mol Sci. 2023 May 9;24(10):8470. doi: 10.3390/ijms24108470. Int J Mol Sci. 2023. PMID: 37239815 Free PMC article. Review. - Transcriptomic insights into adenoid cystic carcinoma via RNA sequencing.
Tang YF, An PG, Gu BX, Yi S, Hu X, Wu WJ, Zhang J. Tang YF, et al. Front Genet. 2023 Apr 21;14:1144945. doi: 10.3389/fgene.2023.1144945. eCollection 2023. Front Genet. 2023. PMID: 37152992 Free PMC article. - Monocyte and Macrophage in Neuroblastoma: Blocking Their Pro-Tumoral Functions and Strengthening Their Crosstalk with Natural Killer Cells.
Vitale C, Bottino C, Castriconi R. Vitale C, et al. Cells. 2023 Mar 13;12(6):885. doi: 10.3390/cells12060885. Cells. 2023. PMID: 36980226 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials